Rumensin

About Elanco

Elanco Animal Health, spun off from Eli Lilly in 2018, is one of the world's largest animal health companies serving veterinarians, pet owners, and farmers globally. The company's diverse portfolio includes vaccines, parasiticides, antibiotics, and other therapeutics for both companion animals and food-producing animals. With significant R&D investments and strategic acquisitions including Bayer Animal Health, Elanco continues to expand its market leadership in the growing animal health sector.

Therapeutic Areas